Janel Corp (OTC:JANL)
| Market Cap | 60.53M+41.7% |
| Revenue (ttm) | 237.21M+16.0% |
| Net Income | 5.90M+97.5% |
| EPS | 4.51+126.8% |
| Shares Out | 1.19M |
| PE Ratio | 11.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 655 |
| Open | 51.10 |
| Previous Close | 51.02 |
| Day's Range | 51.02 - 51.10 |
| 52-Week Range | 21.00 - 58.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
JANEL CORP has a live Insider Score.
Scored on 3 qualifying trades from 1 insider in the last 90 days.
About JANL
Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries. The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$JANL stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in JANL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by JANL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
JANL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New JANL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to JANL from public contracts
Source: USAspending.gov
JANL Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from JANL’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score